Quantcast
Last updated on April 19, 2014 at 1:20 EDT

Latest Thrombosis Stories

2013-10-19 23:04:12

The Nashville-based vein center says that vein disease can affect anyone at any time, but that there are some risk factors that increase the incidence of this condition. Nashville, TN (PRWEB) October 19, 2013 The Siragusa Vein and Vascular Center has produced an article describing the risk factors for vein disease. The Nashville-based vein center says that vein disease can affect anyone at any time, but that there are some risk factors that increase the incidence of this condition. They...

2013-10-17 16:25:11

BOSTON, Oct. 17, 2013 /PRNewswire/ -- The North American Thrombosis Forum (NATF) has launched an innovative educational initiative on risk assessment and anticoagulation for stroke prevention in atrial fibrillation (AF). The AF Action Initiative, led by Christian Ruff, MD, MPH, Investigator at the TIMI Study Group and Associate Physician, Cardiovascular Division at Brigham and Women's Hospital, will convene a consensus group of 29 expert researchers and clinicians in the U.S.,...

2013-10-11 23:22:44

Additional models added to list eligible for free consultation from national network of attorneys reviewing allegations of serious side effects, including deep vein thrombosis, filter fracture, migration and perforation for which consumers may be eligible for compensation. San Diego, CA (PRWEB) October 11, 2013 Resource4thePeople announced today that it has important news for consumers seeking information about seeking compensation in cases involving allegations of life-threatening side...

2013-10-07 16:23:17

Northwestern Medicine study suggests postoperative blood clot rate measure is flawed CHICAGO, Oct. 7, 2013 /PRNewswire-USNewswire/ -- A study published today in JAMA by Northwestern Medicine(®) researchers suggests that a publicly reported outcomes quality measure, meant to reflect a hospital's success in preventing blood clots following a surgery, is fundamentally flawed. The measure, known as PSI-12 VTE, was designed to measure the rates of patients with postoperative venous...

2013-10-03 12:26:45

OR AKIVA, Israel, October 3, 2013 /PRNewswire/ -- On Wednesday, October 2, the clinical effectiveness research results associated with the ActiveCare(R) were featured in the prestigious Charnley Lecture at the British Orthopaedic Association Congress (BOA) in Birmingham, England. Dr. Robert Barrack, Chief of Orthopedics at Barnes Jewish Hospital (BJC), St. Louis, Missouri, USA presented the Charnley Lecture titled "The History of Thromboprophylaxis in Hip and Knee Replacement...

2013-09-18 23:28:29

Siragusa Vein and Vascular Center is launching a new social media campaign to educate the public about potentially deadly deep vein thrombosis (PRWEB) September 18, 2013 The Siragusa Vein and Vascular Center is launching a new social media campaign to educate the public about the risks of deep vein thrombosis, or blood clots – a potentially deadly complication of vein disease. According to the Nashville, Tennessee Center, modern ultrasound techniques can be used to diagnose and remove...

2013-09-12 23:29:13

Yaz Settlements Have Been Reached in More 6,700 Yaz and Yasmin Lawsuits Filed on Behalf of Women Who Suffered Deep Vein Thrombosis, Pulmonary Embolism, and Other Dangerous Blood Clots, Allegedly Associated with the Use of Yaz and Yasmin Birth Control Pills. Columbus, OH (PRWEB) September 12, 2013 The Yaz lawsuit lawyers at Wright & Schulte LLC, an experienced law firm representing the victims of defective drugs, applaud a recent disclosure that Bayer has reached Yaz and Yasmin lawsuit...

2013-09-12 12:29:40

BOSTON, Sept. 12, 2013 /PRNewswire/ -- The North American Thrombosis Forum (NATF), a Boston-based non-profit organization, combined efforts with a group of patient advocates in Georgia to increase thrombosis education. That goal was achieved, designating September as Thrombosis Awareness Month in the state of Georgia. At a press conference at the Georgia State House on August 2, 2013, State Senator Renee Unterman announced the passing of a Resolution proclaiming September as...

2013-09-08 23:00:05

A NuvaRing pulmonary embolism lawsuit recently filed by Alonso Krangle alleges that the plaintiff’s use of NuvaRing caused her to develop a pulmonary embolism. This case also contends that Organon, the manufacturer of NuvaRing, knew about the significant risk of serious NuvaRing side effects and, yet, did not alert the public about these risks. New York, NY (PRWEB) September 08, 2013 Alonso Krangle’s attorneys have recently filed a NuvaRing pulmonary embolism lawsuit on behalf of a...

2013-09-06 12:25:31

Coating artery-opening stents with a new compound may someday eliminate a common side effect of the treatment, according to preliminary research in the American Heart Association journal Arteriosclerosis, Thrombosis, and Vascular Biology. Stents are tiny mesh tubes that prop open clogged arteries so blood will flow freely to heart muscle, relieving chest pain and reducing the risk of heart attack. But implanting a stent damages the inner lining of the artery, triggering overgrowth of...